Cerus Corporation (FRA:CU2)
1.906
-0.037 (-1.90%)
At close: Jan 30, 2026
Cerus Revenue
Cerus had revenue of $60.24M USD in the quarter ending September 30, 2025, with 18.91% growth. This brings the company's revenue in the last twelve months to $225.97M, up 14.18% year-over-year. In the year 2024, Cerus had annual revenue of $201.32M with 7.78% growth.
Revenue (ttm)
$225.97M
Revenue Growth
+14.18%
P/S Ratio
2.22
Revenue / Employee
$358.68K
Employees
630
Market Cap
376.71M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 201.32M | 14.52M | 7.78% |
| Dec 31, 2023 | 186.80M | -1.52M | -0.81% |
| Dec 31, 2022 | 188.32M | 28.80M | 18.05% |
| Dec 31, 2021 | 159.52M | 45.27M | 39.62% |
| Dec 31, 2020 | 114.25M | 20.48M | 21.83% |
| Dec 31, 2019 | 93.77M | 17.72M | 23.30% |
| Dec 31, 2018 | 76.05M | 24.73M | 48.17% |
| Dec 31, 2017 | 51.33M | 12.05M | 30.68% |
| Dec 31, 2016 | 39.28M | 5.05M | 14.76% |
| Dec 31, 2015 | 34.22M | -2.19M | -6.02% |
| Dec 31, 2014 | 36.42M | -3.24M | -8.17% |
| Dec 31, 2013 | 39.66M | 2.87M | 7.80% |
| Dec 31, 2012 | 36.79M | 3.74M | 11.32% |
| Dec 31, 2011 | 33.04M | 9.94M | 42.99% |
| Dec 31, 2010 | 23.11M | 5.13M | 28.51% |
| Dec 31, 2009 | 17.98M | 1.48M | 8.94% |
| Dec 31, 2008 | 16.51M | 5.46M | 49.47% |
| Dec 31, 2007 | 11.04M | -19.27M | -63.56% |
| Dec 31, 2006 | 30.31M | 16.81M | 124.57% |
| Dec 31, 2005 | 13.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| FRoSTA Aktiengesellschaft | 652.00M |
| SIMONA Aktiengesellschaft | 586.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| centrotherm international AG | 288.81M |
| Novabase S.G.P.S. | 130.35M |
| Wild Bunch AG | 68.86M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |
Cerus News
- 10 days ago - DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT Blood System in Routine Clinical Practice - Wallstreet:Online
- 10 days ago - DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice - Business Wire
- 11 days ago - Secure Asset Management, LLC Sells 10,000 Shares of Cerus Corp (CERS) - GuruFocus
- 20 days ago - Cerus (CERS) Reports Strong Revenue Growth Driven by INTERCEPT Fibrinogen Complex - GuruFocus
- 20 days ago - CERS Projects Revenue Growth in 2026 - GuruFocus
- 20 days ago - Cerus (CERS) Reports Significant Global Expansion of INTERCEPT Blood Components in 2025 - GuruFocus
- 20 days ago - Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Wallstreet:Online
- 20 days ago - Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Business Wire